In recognition of both Health Literacy Month and Breast Cancer Awareness Month, we’re looking at the unmet treatment education needs of people living with breast cancer who experience low health literacy.
Patient-reported outcomes in metastatic breast cancer: delivering multistakeholder value through patient centricityPrime Global 13 October, 2022
October is World Breast Cancer Awareness Month, and 13 October is Metastatic Breast Cancer Awareness Day. Let’s look at how the views of people living with metastatic breast cancer provide a vital, underestimated component of assessing the benefits of novel treatments.
An estimated 57.4 million people live with dementia worldwide, (1) and unfortunately, clinical trials for dementia treatments have resulted in few pharmacotherapies – none of them curative. (2) (3) (4) For World Alzheimer’s Day, Prime Patient explore how Pharma can collaborate with people living with dementia to optimise the industry’s dementia research and patient community support.
We are delighted to have been featured in MM+M’s article, A medical marketing blind spot: LGBTQIA+ communities being left behind.read more >>
Many agree that disability inclusion in clinical trials is a worthy pursuit, but the historical significance and future impact of pursuing this goal is relatively unexplored. Here, we peel back the layers of this vital mission.
We take a look at the value of patient data, how it can impact Pharma and to what extent it could benefit the industry.
For Pride Month 2022, Prime Patient investigate how Pharma can build stronger, more productive relationships with the LGBTQIA+ community
This Pride Month, Prime Patient takes a close look at the health inequity faced by the transgender community, and what we can do about it.
This month, the results of the 2021 PatientView corporate reputation survey were released. With insights from 240 US patient groups, a number of key findings were reported; here, we take a closer look.
On May 24th, the Prime Patient team was fortunate to have a spot at 2022’s Patient Centricity and Engagement Conference, hosted in London, England. With a veritable smorgasbord of topics up for discussion, we were spoiled for choice! Here we summarise some highlights from the day, kicking off with tips on strengthening patient advocacy collaboration.
Haemophilia is a lifelong genetic disorder characterised by excessive bleeding.(1) Despite the existence of treatments for haemophilia, the condition continues to have major impacts on quality of life, for example in the areas of pain (acute and chronic), joint mobility, and physical function.(1) To mark World Haemophilia Day on 17 April, Prime Patient partnered with sister agency HCD Economics, a consultancy specialising in haemophilia patient research, and haemophilia advocate Laurence Woollard to better understand the existing relationship between patients and industry and how meaningful improvements can be made to the lives of people living with haemophilia (PwH).
Patient advocacy and engagement are important no matter the disease area, whether it’s a common condition or one that few have heard of. Following the recent celebration of Rare Disease Day, let’s take a closer look at patient engagement in rare mutation cancers.
In the spirit of Rare Disease Day, which was celebrated on 28 February, we’re looking at the importance of patient engagement in lysosomal storage disorders (LSDs).
Medical publishing is evolving beyond plain language summaries to provide insightful, patient-centred resources to change the course of pharmaceutical research for the better. For patients with rare diseases especially, this could be just what the doctor ordered, writes Olivia Kersey, Patient Engagement Strategist with Prime Patient.
Rare reflections: has the pandemic helped or hindered patient engagement and research for rare diseases?Prime Global 28 February, 2022
Emma Sutcliffe, SVP Patient Insights and Solutions, Prime Patient shares her reflections about whether the pandemic has helped or hindered patient engagement and research for rare diseases.
To mark Breast Cancer Awareness Month, we picked the brains of two of our experts! Farai Muldoon, Client Services Director, and Kiran Nandra, Scientific Team Lead, draw on their experience to give insight into how medical communications plays a role in breast cancer.read more >>
We’re talking all things vaccines! With a combined vaccine experience of nearly 20 years, Gaurav Kumar, Group Managing Director, and Elien Moes, Director Scientific Services, are perfectly suited to answer all our questions about immunisation and medical communications. They share their work on vaccine education and development, and even touch on the opportunities they have had to witness worldwide vaccine cultures first-hand.read more >>
My name is José Antonio Barrientos and I’m a Client Services Director at Prime Global. In 2017 I was diagnosed with testicular cancer, and this post captures the week that changed my life.read more >>
It’s Movember! Movember was founded to improve awareness of men’s health worldwide, particularly around prostate cancer, testicular cancer and mental health.
Today, we’re focusing on testicular cancer.read more >>